Published on 04/10/2022
The INCISIVE team working on the user requirement definition, led by Shereen Nabhani-Gebara, Associate Professor of Oncology Pharmacy at the Kingston University London, published the article ‘Experiences of cancer survivors in Europe: Has anything changed? Can artificial intelligence offer a solution?’ in the Cancer Epidemiology and Prevention section of Frontiers in Oncology.
INCISIVE researchers conducted a qualitative study that consisted of 40 in-depth interviews with cancer survivors from five European countries: Greece, Italy, Serbia, Cyprus, and Spain. The article includes verbatim excerpts from patients diagnosed with breast, colorectal, prostate, or lung cancer at least six months before the interview.
The results of the study revealed that cancer survivors experienced significant burdens on cancer diagnosis and treatment. Specifically, five key common themes were identified:
According to Nabhani-Gebara, “the most interesting part of our article is that there are many shared difficulties across the cancer journey in the five European countries. The delayed diagnosis was one of the main problems across all countries, precipitating significant physical and psychological impacts on the patients. This highlights the importance and potential impact of INCISIVE in addressing these bottlenecks by enhancing the diagnostic process”. Thus, the article concludes that some of the uncovered aspects from cancer survivors’ perspectives could be optimised using AI technology to speed up the diagnostic process and increase diagnostic accuracy.